Notably, tirzepatide is a dual incretin receptor agonist that activates both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor, distinguishing it from other GLP-1-specific agonists
Kaplonek P, Cizmeci D, Fischinger S, Collier AR, Suscovich T, Linde C, et al
From Wikimedia Commons, the free media repository File File history File usage on Commons File usage on other wikis Original file (3,334 681 pixels, file size: 123 KB, MIME type: image/png) File information Structured data Captions Captions Allspring Global Investments File history Click on a date/time to view the file as it appeared at that time
Moreover, we believe that employers (that offer or sponsor employee health plans), researchers, policy officials, and similar members of the public could utilize this data to promote competition and choice, ultimately helping to improve healthcare value
PMID: 175 Sinisterra LoaizaLIFernndez-EdreiraDLiares-BlancoJCepedaACardelle-CobasAFernndez-LozanoC
Therapeutic peptides are emerging as promising drug candidates, garnering significant attention in the field of medicine and drug development due to their high specificity, affinity, and low toxicity [1-3]